Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
WTF are fandoms, and why are marketers chasing them?
Marketers want more than customers. They’re chasing fandom to turn audiences into communities.
OpenAI is sharpening its focus on enterprise advertisers
The company is hiring a dedicated marketing role aimed at positioning OpenAI as a ‘premium advertising platform for the world’s marketers’.
The new AI playbook: The rules brands are setting around customer-facing content
For some brands, AI platforms and services are proving to be game-changing for their ability to speed up creative processes, and save money.